About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Market Research
Bispecific Antibodies Market Expected to Grow at 5.9% by 2029
Bispecific Antibodies Market By Type (Immunoglobulin G (IgG) Like Molecule, Non Immunoglobulin G (IgG) Like Molecule), by Application (Oncology, Autoimmune Disease, Others) - Growth, Future Prospects & Competitive Analysis, 2021 – 2029
26 Dec 2018
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Bispecific Antibodies Market
2.2. Global Bispecific Antibodies Market, By Type, 2023 (US$ Million)
2.3. Global Bispecific Antibodies Market, By Application, 2023 (US$ Million)
2.4. Global Bispecific Antibodies Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Bispecific Antibodies Market: Competitive Analysis
3.1. Market Positioning of Key Bispecific Antibodies Market Vendors
3.2. Strategies Adopted by Bispecific Antibodies Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Bispecific Antibodies Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Bispecific Antibodies Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Immunoglobulin G (IgG) Like Molecule
5.3.2. Non Immunoglobulin G (IgG) Like Molecule
6. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Oncology
6.3.2. Autoimmune Disease
6.3.3. Others
7. North America Bispecific Antibodies Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
7.3. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
7.4.Bispecific Antibodies Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
7.4.1.1.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
7.4.1.2.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
7.4.1.3.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
8. UK and European Union Bispecific Antibodies Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
8.3. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
8.4.Bispecific Antibodies Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
8.4.1.1.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
8.4.1.2.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
8.4.1.3.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
8.4.1.4.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
8.4.1.5.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
8.4.1.6.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
9. Asia Pacific Bispecific Antibodies Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
9.3. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
9.4.Bispecific Antibodies Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
9.4.1.1.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
9.4.1.2.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
9.4.1.3.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
9.4.1.4.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
9.4.1.5.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
9.4.1.6.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
10. Latin America Bispecific Antibodies Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
10.3. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
10.4.Bispecific Antibodies Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
10.4.1.1.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
10.4.1.2.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
10.4.1.3.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
11. Middle East and Africa Bispecific Antibodies Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
11.3. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
11.4.Bispecific Antibodies Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
11.4.1.1.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
11.4.1.2.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Bispecific Antibodies Market: By Type, 2022-2032, USD (Million)
11.4.1.3.2. Bispecific Antibodies Market: By Application, 2022-2032, USD (Million)
12. Company Profile
12.1. Amgen, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Ablynx
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Eli Lilly and Company
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. F. Hoffmann-La Roche AG
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Janssen Global Services, LLC
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Merck Group
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Merrimack Pharmaceuticals
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Neovii Biotech
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. OncoMed Pharmaceuticals, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Regeneron Pharmaceuticals
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4325
Multi User license
$6325
Corporate license
$12650
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234